Learn more about our Advocacy work.
The Advanced Medical Technology Association® (AdvaMed®) today announced that Bobby Patrick will join the Association as vice president of state government and regional affairs and Roxy Kozyckyj will join as director of…
AdvaMed® released the following statement from President and CEO Scott Whitaker regarding the final Physician Fee Schedule rule released yesterday by the Centers for Medicare and Medicaid Services (CMS):
As medtech innovation outpaces coding and payment systems designed for another era, the threat of meritless False Claims Act cases deters important advancement in technologies patients need.
Nadim Yared, President and CEO of medical technology startup CVRx, recently joined AdvaMed®’s Scott Whitaker on the Medtech POV Podcast to discuss his expansive medtech career – from engineer to CEO –…
Today, the Advanced Medical Technology Association® (AdvaMed®) submitted comments to the Centers for Medicare & Medicaid Services (CMS) on its proposal to repeal the Medicare Coverage of Innovative Technology (MCIT)…
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government’s access to safety injection devices through increased manufacturing capacity…
The MedTech Conference, the Advanced Medical Technology Association®’s (AdvaMed®) premier annual gathering, wrapped up Thursday following four days of networking opportunities, presentations and panel discussions on the top issues facing…
A new study commissioned by the Advanced Medical Technology Association® (AdvaMed®) found that two-thirds of medical technology companies say semiconductors, firmware, and/or embedded software are required for at least half of the…
From September 27-30, The Medtech Conference 2021 will host a robust line-up of thought leaders from inside and outside the health care arena to discuss the top issues facing the medical technology industry and…
In the most recent episode of the Medtech POV Podcast, a top medtech venture capital investor argued that if a medical device has received FDA approval as safe and effective…